Last edition
News about "AiTEM platform"
METiS TechBio's AI-Designed Drug MTS-004 Completes Phase III Trial for Pseudobulbar Affect
METiS TechBio, a global leader in AI-driven nanodelivery and formulation innovation, has announced that its small-molecule candidate MTS-004 has successfully met the primary endpoint in its Phase III clinical trial.
AiTEM Platform | 24/10/2025 | By Dineshwori | 141
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members